BioNano Genomics Inc vs Advanced Drainage Systems Inc — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while Advanced Drainage Systems Inc trades at $147.16 (market cap $11.57B). The key difference: Advanced Drainage Systems Inc is far larger — about 876.5× BioNano Genomics Inc's market cap, and Advanced Drainage Systems Inc pays a 0.53% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | WMS | |
|---|---|---|
Market Cap | $13.20M | $11.57B |
Sector | Health | Industrials |
52-Week High | $4.92 | $175.38 |
52-Week Low | $1.09 | $110.89 |
Enterprise Value | $15.81M | $13.14B |
Dividend Yield | — | 0.53% |
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
WMS trades at $147.62, down 1.89% on the day, with a bullish technical signal and strong fundamentals including a 24.02% ROE and consistent earnings beats. Recent news includes a dividend increase and investor day, while cash flow dipped in 2025 but is projected to recover. The stock shows robust profitability with a 13.98% net margin and trades below the consensus price target of $184.43.
Outlook is positive with analyst support and operational strength, but risks include a high P/E of 27.09 and mixed sentiment from recent Strong Sell ratings. Upside potential exists if earnings momentum continues, though investors should monitor debt levels and competitive pressures in the water management sector.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →